With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
Health financing and payment, results-based financing, social protection, conditional cash transfer programs, noncommunicable disease, maternal and child health
Amanda Glassman is chief operating officer and senior fellow at the Center for Global Development and also serves as secretary of the board. Her research focuses on priority-setting, resource allocation and value for money in global health, as well as data for development. Prior to her current position, she served as director for global health policy at the Center from 2010 to 2016, and has more than 25 years of experience working on health and social protection policy and programs in Latin America and elsewhere in the developing world.
Prior to joining CGD, Glassman was principal technical lead for health at the Inter-American Development Bank, where she led policy dialogue with member countries, designed the results-based grant program Salud Mesoamerica 2015 and served as team leader for conditional cash transfer programs such as Mexico’s Oportunidades and Colombia’s Familias en Accion. From 2005-2007, Glassman was deputy director of the Global Health Financing Initiative at Brookings and carried out policy research on aid effectiveness and domestic financing issues in the health sector in low-income countries. Before joining the Brookings Institution, Glassman designed, supervised and evaluated health and social protection loans at the Inter-American Development Bank and worked as a Population Reference Bureau Fellow at the US Agency for International Development. Glassman holds a MSc from the Harvard School of Public Health and a BA from Brown University, has published on a wide range of health and social protection finance and policy topics, and is editor and coauthor of the books Millions Saved: New Cases of Proven Success in Global Health (Center for Global Development 2016), From Few to Many: A Decade of Health Insurance Expansion in Colombia (IDB and Brookings 2010), and The Health of Women in Latin America and the Caribbean (World Bank 2001).
In 2013, a CGD working group signaled important benefits of development impact bonds, and worked through some of the “how-to” of design and implementation. Yet five years later, only three development impact bonds have launched. Why is this the case? Why is it so hard to get DIBs off the ground? What can we learn from the structuring and financing of DIBs to date to ease the way for future efforts?
The launch of the Cameroon Cataract Development Impact Loan—a Development Impact Bond (DIB) to provide cataract surgery services via a social enterprise model—marks a key moment in the history of results-based financing. The cataract bond is the first DIB to have a development finance institution (DFI) as an investor, and among the first pay-for-performance projects in eye care to assess the quantity, quality, equity, and financial sustainability of the services provided. Please join us for a discussion on the development of the bond and the experiences of the cataract bond partner organizations, as well as lessons learned from other health-related impact bonds and what it all suggests for the future of pay-for-success for health.
Here at CGD, we’re always working on new ideas to stay on top of the rapidly changing global development landscape. Whether it’s examining new technologies with the potential to alleviate poverty, presenting innovative ways to finance global health, assessing changing leadership at international institutions, or working to maximize results in resource-constrained environments, CGD’s experts are at the forefront of practical policy solutions to reduce global poverty and inequality. Get an in-depth look below at their thoughts on the 2018 global development landscape.
What's going to happen in the world of development in 2018? Will we finally understand how to deal equitably with refugees and migrants? Or how technological progress can work for developing countries? Or what the impact of year two of the Trump Administration will be? Today’s podcast, our final episode of 2017, raises these questions and many more as a multitude of CGD scholars share their insights and hopes for the year ahead.
Please join CGD for a conversation with four former directors of USAID’s Office of Population and Reproductive Health. These four leaders served between 1986 and 2013—and their tenures have spanned US administrations from Ronald Reagan to Barack Obama. Since the Office’s inception in 1969, the US government has played a substantial role in supporting expanded access to voluntary family planning around the world through technical assistance, diplomatic and policy engagement, and financial support. But differences in policy across administrations have meant that US leadership in international family planning has often faced periods of uncertainty. CGD is convening this panel to revisit historic experiences and to shed light on lessons learned that may be used to inform stakeholders in the current landscape.
Researchers from many academic institutions and think tanks have studied the relationship between contraception and women's economic empowerment. In both the developing and developed world, the evidence suggests that access to contraception is not only correlated with but can even cause women’s economic empowerment and drive economic growth.
Since the term “data revolution” was brandished in the High-Level Panel report on the Post-2015 Development Agenda, there has been a great deal of activity to define, develop, and drive an agenda that could transform the way development statistics are collected and used throughout the world. But nowhere is the need for better data more urgent than in sub-Saharan Africa. Despite a decade of rapid economic growth in most countries, the accuracy of many types of basic data remains low, and improvements have been sluggish.
Country action should drive the data revolution from the bottom up, but high-level activities surrounding the post-2015 development agenda can and must help catalyze progress on national statistics. This event will highlight the need for more timely, accurate, and open data in Africa, and discuss strategies to help national governments, donors, technical agencies, and the producers and users of statistics to drive a data revolution that can be led and sustained in the region.
The event will mark the launch of the Data for African Development Working Group report, Delivering on the Data Revolution in Sub-Saharan Africa, co-chaired by Amanda Glassman from the Center for Global Development and Alex Ezeh from the African Population Health and Research Center in Nairobi, Kenya.
Across multiple African countries, discrepancies between administrative data and independent household surveys suggest official statistics systematically exaggerate development progress. We provide evidence for two distinct explanations of these discrepancies.
This report offers a strategy for the Global Fund to get more health for the money by focusing more on results, maximizing cost-effectiveness, and systematically measuring performance throughout its operations.
Since 2015, India has devolved an increasing share of its national tax yield to state governments and undertaken reforms to other kinds of centre-to-state grants. For many, the increased revenue via the tax devolution was considered good news but some health experts worried that states would give little priority to health under these conditions of greater autonomy. We find that at least two states, Bihar and Uttar Pradesh, have much more to spend in general and are budgeting more for health in 2015-2016 as compared to previous fiscal years.
In the absence of effective international institutions, the United States has become the world’s de facto first responder for global health crises such as HIV/AIDS and new threats like Ebola. The US government has the technical know-how, financial and logistical resources, and unparalleled political support to act quickly and save lives. Initiatives such as the President’s Emergency Plan for AIDS Relief (PEPFAR) and the President’s Malaria Initiative are widely considered among the most effective aid programs in the world.
Yet US global health approaches are based on increasingly outdated engagement models, which fail to reflect emerging challenges, threats, and financial constraints. The next US president, working closely with Congress, should modernize how US global health programs are organized, deployed, and overseen. By taking three specific steps, the United States can reduce the need for costly first responses and generate more health and economic impact for every US taxpayer dollar spent.